NT5C1A (5-nucleotidase, cytosolic IA)

2019-08-01  

Identity

HGNC
LOCATION
1p34.2
LOCUSID
ALIAS
CN-I,CN-IA,CN1,CN1A,CNI

Other Information

Locus ID:

NCBI: 84618
MIM: 610525
HGNC: 17819
Ensembl: ENSG00000116981

Variants:

dbSNP: 84618
ClinVar: 84618
TCGA: ENSG00000116981
COSMIC: NT5C1A

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000116981ENST00000235628Q9BXI3

Expression (GTEx)

0
5
10
15

Pathways

PathwaySourceExternal ID
Purine metabolismKEGGko00230
Pyrimidine metabolismKEGGko00240
Nicotinate and nicotinamide metabolismKEGGko00760
Purine metabolismKEGGhsa00230
Pyrimidine metabolismKEGGhsa00240
Nicotinate and nicotinamide metabolismKEGGhsa00760
Metabolic pathwaysKEGGhsa01100
MetabolismREACTOMER-HSA-1430728
Metabolism of nucleotidesREACTOMER-HSA-15869
Purine metabolismREACTOMER-HSA-73847
Purine catabolismREACTOMER-HSA-74259
Pyrimidine metabolismREACTOMER-HSA-73848
Pyrimidine catabolismREACTOMER-HSA-73621

Protein levels (Protein atlas)

Not detected
Low
Medium
High

PharmGKB

Entity IDNameTypeEvidenceAssociationPKPDPMIDs
PA128406956fluorouracilChemicalClinicalAnnotationassociated26906009
PA449027cladribineChemicalClinicalAnnotationassociated26906009
PA449748gemcitabineChemicalClinicalAnnotationassociated26906009

References

Pubmed IDYearTitleCitations
307097692019Cytosolic 5'-nucleotidase 1A is overexpressed in pancreatic cancer and mediates gemcitabine resistance by reducing intracellular gemcitabine metabolites.14
310245692019Anti-NT5c1A Autoantibodies as Biomarkers in Inclusion Body Myositis.19
307097692019Cytosolic 5'-nucleotidase 1A is overexpressed in pancreatic cancer and mediates gemcitabine resistance by reducing intracellular gemcitabine metabolites.14
310245692019Anti-NT5c1A Autoantibodies as Biomarkers in Inclusion Body Myositis.19
258576612016Seropositivity for NT5c1A antibody in sporadic inclusion body myositis predicts more severe motor, bulbar and respiratory involvement.27
258920102016Cytosolic 5'-Nucleotidase 1A As a Target of Circulating Autoantibodies in Autoimmune Diseases.29
269060092016Pharmacogenetic characterization of naturally occurring germline NT5C1A variants to chemotherapeutic nucleoside analogs.1
258576612016Seropositivity for NT5c1A antibody in sporadic inclusion body myositis predicts more severe motor, bulbar and respiratory involvement.27
258920102016Cytosolic 5'-Nucleotidase 1A As a Target of Circulating Autoantibodies in Autoimmune Diseases.29
269060092016Pharmacogenetic characterization of naturally occurring germline NT5C1A variants to chemotherapeutic nucleoside analogs.1
218734332011Suppression of 5'-nucleotidase enzymes promotes AMP-activated protein kinase (AMPK) phosphorylation and metabolism in human and mouse skeletal muscle.32
218734332011Suppression of 5'-nucleotidase enzymes promotes AMP-activated protein kinase (AMPK) phosphorylation and metabolism in human and mouse skeletal muscle.32
193525422009Expression of cytosolic 5' nucleotidase does not correlate with expression of oxidative metabolism marker: myoglobine in human skeletal muscles.1
193525422009Expression of cytosolic 5' nucleotidase does not correlate with expression of oxidative metabolism marker: myoglobine in human skeletal muscles.1
170650912006Cell cycle dependent regulation of deoxycytidine kinase, deoxyguanosine kinase, and cytosolic 5'-nucleotidase I activity in MOLT-4 cells.0

Citation

Dessen P

NT5C1A (5-nucleotidase, cytosolic IA)

Atlas Genet Cytogenet Oncol Haematol. 2019-08-01

Online version: http://atlasgeneticsoncology.org/gene/58069/css/gene-explorer/favicon/favicon-16x16.png